KHRN.V
Price:
$0.04
Market Cap:
$9.30M
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-05-24
Stock Exchange
TSXV
Ticker
KHRN.V
According to Khiron Life Sciences Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.24. This represents a change of -83.49% compared to the average of -1.42 of the last 4 quarters.
The mean historical PE Ratio of Khiron Life Sciences Corp. over the last ten years is -1.96. The current -0.24 PE Ratio has changed 1.10% with respect to the historical average. Over the past ten years (40 quarters), KHRN.V's PE Ratio was at its highest in in the September 2022 quarter at -1.42. The PE Ratio was at its lowest in in the September 2022 quarter at -1.42.
Average
-1.96
Median
-1.88
Minimum
-2.97
Maximum
-1.04
Discovering the peaks and valleys of Khiron Life Sciences Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -1.04
Minimum Annual Increase = -44.43%
Minimum Annual PE Ratio = -2.97
Year | PE Ratio | Change |
---|---|---|
2021 | -1.04 | -44.43% |
2020 | -1.88 | -36.84% |
The current PE Ratio of Khiron Life Sciences Corp. (KHRN.V) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.96
5-year avg
-1.96
10-year avg
-1.96
Khiron Life Sciences Corp.’s PE Ratio is greater than iAnthus Capital Holdings, Inc. (-0.76), greater than PharmaCielo Ltd. (-1.08), greater than MedMen Enterprises Inc. (-0.42), greater than Curaleaf Holdings, Inc. (-5.66), greater than 1933 Industries Inc. (-0.25),
Company | PE Ratio | Market cap |
---|---|---|
-0.76 | $66.27M | |
-1.08 | $12.74M | |
-0.42 | $27.66M | |
-5.66 | $4.07B | |
-0.25 | $4.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Khiron Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Khiron Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Khiron Life Sciences Corp.'s PE Ratio?
How is the PE Ratio calculated for Khiron Life Sciences Corp. (KHRN.V)?
What is the highest PE Ratio for Khiron Life Sciences Corp. (KHRN.V)?
What is the 3-year average PE Ratio for Khiron Life Sciences Corp. (KHRN.V)?
What is the 5-year average PE Ratio for Khiron Life Sciences Corp. (KHRN.V)?
How does the current PE Ratio for Khiron Life Sciences Corp. (KHRN.V) compare to its historical average?